| Headache: A striking prodromal and persistent symptom, predictive of COVID-19 clinical evolution E Caronna, A Ballvé, A Llauradó, VJ Gallardo, DM Ariton, S Lallana, ... Cephalalgia 40 (13), 1410-1421, 2020 | 255 | 2020 |
| From transformation to chronification of migraine: pathophysiological and clinical aspects M Torres-Ferrús, F Ursitti, A Alpuente, F Brunello, D Chiappino, T de Vries, ... The journal of headache and pain 21, 1-12, 2020 | 106 | 2020 |
| Anti-CGRP monoclonal antibodies in chronic migraine with medication overuse: real-life effectiveness and predictors of response at 6 months E Caronna, VJ Gallardo, A Alpuente, M Torres-Ferrus, P Pozo-Rosich The journal of headache and pain 22, 1-7, 2021 | 79 | 2021 |
| The impact of anti-CGRP monoclonal antibodies in resistant migraine patients: a real-world evidence observational study M Torres-Ferrús, VJ Gallardo, A Alpuente, E Caronna, E Gine-Cipres, ... Journal of Neurology, 1-10, 2021 | 67 | 2021 |
| Toward a better understanding of persistent headache after mild COVID‐19: three migraine‐like yet distinct scenarios E Caronna, A Alpuente, M Torres‐Ferrus, P Pozo‐Rosich Headache: The Journal of Head and Face Pain 61 (8), 1277-1280, 2021 | 65 | 2021 |
| Salivary CGRP can monitor the different migraine phases: CGRP (in) dependent attacks A Alpuente, VJ Gallardo, L Asskour, E Caronna, M Torres-Ferrus, ... Cephalalgia 42 (3), 186-196, 2022 | 52 | 2022 |
| Salivary CGRP and erenumab treatment response: towards precision medicine in migraine A Alpuente, VJ Gallardo, L Asskour, E Caronna, M Torres‐Ferrus, ... Annals of Neurology 92 (5), 846-859, 2022 | 48 | 2022 |
| MAB-MIG: registry of the spanish neurological society of erenumab for migraine prevention R Belvís, P Irimia, P Pozo-Rosich, C González-Oria, A Cano, J Viguera, ... The Journal of Headache and Pain 22, 1-8, 2021 | 39 | 2021 |
| Influence of headache pain intensity and frequency on migraine-related disability in chronic migraine patients treated with OnabotulinumtoxinA M Torres-Ferrus, VJ Gallardo, A Alpuente, P Pozo-Rosich The journal of headache and pain 21, 1-8, 2020 | 38 | 2020 |
| Effectiveness and safety of anti-CGRP monoclonal antibodies in patients over 65 years: a real-life multicentre analysis of 162 patients A Muñoz-Vendrell, S Campoy, E Caronna, A Alpuente, M Torres-Ferrus, ... The Journal of Headache and Pain 24 (1), 63, 2023 | 26 | 2023 |
